Abstract:As one of the most important organelles in most eukaryotic cells,mitochondria not only supply cellular energy,but also involve in a range of other processes,such as cellular differentiation,cell death,as well as the control of the cell cycle and cell growth.Besides,cancer cell mitochondria exhibit an extensive metabolic activity and are more susceptible to mitochondrial perturbation than normal cell mitochondria.Consequently,induction of apoptosis through targeting of mitochondria of cancer cells can be an effective therapy strategy.Here,we conducted a hierarchical targeted delivery system that could deliver the chemotherapeutic agents,resveratrol (1),sequentially to tumor cells and mitochondria.In detail,the mitochondrial targeting prodrug triphenylphosphine-resveratrol (TPP-1) was constructed by conjugation.Then,the TPP-1 was entrapped in the lipid bilayer of liposomes.Followed,the liposomes were decorated with polyethylene glycol (PEG) and the cell targeting peptide RGD to form the hierarchical targeted delivery system (RLP-TPP-1 liposomes).The prepared RLP-TPP-1 liposomes were regularly spherical and well-distributed,the average particle size,ζ potential and encapsulation efficiency were (128.1±3.4) nm,(-20.28± 1.68) mV and (75.6±0.8) ％,respectively.The results of in vitro cytotoxicity test showed that the blank liposomes were nontoxic against MDA-MB-231 cells overexpressing αvβ3 receptors.However,the drug-loaded liposomes presented a significant inhibitory effect on MDA-MB-231 cells in a dose-dependent manner.In addition,the IC50 value (4.95 μmol/L) of the RLP-TPP-1 liposomes was the lowest among the tested liposomes.Cellular uptake experiment revealed that the uptake of RGD decorated liposomes were significantly higher than that of the undecorated liposomes.The results of JC-1 staining test showed that the RLP-TPP-1 liposomes performed the best mitochondrial targeting effect and increased apoptosis distinctively.In summary,RLP-TPP-1 liposomes could target to tumor cells and deliver 1 to mitochondria,resulting in the mitochondrial dysfunction and apoptosis of cancer cells.

Preparation and Preliminary in vitro Evaluation of RGD Modified Mitochondrial Targeting Long-circulating Liposomes

Mitochondrial targeted hierarchical drug delivery system based on HA-modified liposomes for cancer therapy

Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria

Stepwise Dual Targeting and Dual Responsive Polymer Micelles for Mitochondrion Therapy.

Preparation of a novel neovessel-targeted PEGylated liposome formulation

The Use of Mitochondrial Targeting Resveratrol Liposomes Modified with a Dequalinium Polyethylene Glycol-Distearoylphosphatidyl Ethanolamine Conjugate to Induce Apoptosis in Resistant Lung Cancer Cells

Enhanced Anticancer Efficacy of Paclitaxel Through Multistage Tumor-Targeting Liposomes Modified with RGD and KLA Peptides

Mitochondrion-specific Dendritic Lipopeptide Liposomes for Targeted Sub-Cellular Delivery

Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.

Increased Tumor Targeted Delivery Using a Multistage Liposome System Functionalized with RGD, TAT and Cleavable PEG.

Integrin αvβ3-targeted liposomal drug delivery system for enhanced lung cancer therapy

[Preparation of Doxorubicin-Loaded Stealth Liposomes Modified with RGD Mimetic and Cellular Association in Vitro].

Mitochondria Apoptosis Pathway Synergistically Activated by Hierarchical Targeted Nanoparticles Co-Delivering Sirna and Lonidamine.

Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy:In vitro andin vivo

Long-Circulating Amphiphilic Doxorubicin For Tumor Mitochondria-Specific Targeting

Redox-triggered Activation of Nanocarriers for Mitochondria-Targeting Cancer Chemotherapy.

Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine–docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo

Mitochondria-Targeted Lipid Nanoparticles Loaded with Rotenone as a New Approach for the Treatment of Oncological Diseases

Preparation Of Rgd-Modified Long Circulating Liposome Loading Matrine, And Its In Vitro Anti-Cancer Effects

RGD(Arg-Gly-Asp) Internalized Docetaxel-Loaded Ph Sensitive Liposomes: Preparation, Characterization and Antitumor Efficacy in Vivo and in Vitro.

Stable Peptides Mediated Glioma Targeting Drug Delivery